Navigation Links
Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
Date:1/23/2013

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that two additional patents have been granted related to the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor (VMAT2) NBI-98854.

European Patent Number 2,081,929 was granted in January 2013 by the European Patent Office with an expiration date of November 2027. This patent covers chemical compositions, pharmaceutical compositions and uses of various compounds including our Phase IIb clinical candidate NBI-98854.

In addition to the already issued composition of matter patent, the United States Patent and Trademark Office recently granted a second patent for NBI-98854. United States Patent Number 8,357,697 covers the method of treating hyperkinetic movement disorders using NBI-98854 and will expire in November 2027. This patent is in addition to the previously issued United States Patent Number 8,039,627 which covers the NBI-98854 composition and expires in late 2029.

"We are very pleased to receive this composition of matter patent from the European Patent Office," said Kevin C. Gorman , Chief Executive Officer of Neurocrine Biosciences. "This EU patent, coupled with our new United States methods of use patent, and the existing United States composition of matter patent provide a strong intellectual property estate around NBI-98854. We intend to continue to expand our VMAT2 patent footprint on NBI-98854 and our other VMAT2 inhibitors in early development."

About NBI-98854

VMAT2 is a protein concentrated in the human brain that is primarily responsible for re-packaging and transporting monoamines (dopamine, norepinephrine, serotonin, and histamine) among nerve cells. NBI-98854, developed in the Neurocrine laboratories, is a
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
2. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
4. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
5. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
6. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
7. Neurocrine Biosciences Reports First Quarter 2012 Results
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
10. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
11. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 2014   Royal Philips  (NYSE: PHG, AEX: PHIA) ... new ultrasound system designed to enable global hospitals and ... volumes and cost pressures. Making its debut at the  ... Barcelona this week, Affiniti provides innovative ... fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... Opinion Leaders (KOLs) can be the difference between a ... struggle to effectively map and stratify KOL targets – ... to build the type of strong relationships upon which ... recent research, savvy pharma companies have identified internal inconsistencies ...
(Date:8/29/2014)... YORK , Aug. 29, 2014 Pomerantz ... TMS S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ... filed in United States District Court, Southern District of ... 14-cv-6069, is on behalf of a class consisting of ... February 1, 2013 and July 30, 2014, inclusive (the ...
Breaking Medicine Technology:Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... Addex Pharmaceuticals,announced today the successful completion of ... its lead compound ADX10059 in patients with,gastro-esophageal ... a significant unmet medical need. The study ... esophageal pH, with,statistical significance, and also showed ...
... in Blood Highlight Millennium Leadership in,Personalized Medicine and ... Therapy in Broad Range of Multiple Myeloma Patients ... published in the April 15th issue of Blood ... Pharmaceuticals, Inc. has,discovered biomarkers which may lead to ...
Cached Medicine Technology:Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 2Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 3Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 4Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 2Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 3Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 4Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 6
(Date:8/30/2014)... Serving contented clients since inception, #1 ... Outsourcing is now offering discount for Labor Day ... emphasize on putting forward the best of web development ... dedicated team of professionals and web developers and designers ... even the critical issues of web development and can ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "I had ... because of her crutches," said an inventor from Wetumpka, Ala. ... sights and sounds of the shore, I came up with ... sand." , She created a prototype for the patent-pending Deezers ... accessory enables the individual to use crutches, walkers, or canes ...
(Date:8/30/2014)... In today’s world, a good night’s ... get. Snoring and sleep apnea (a medical problem where ... people and their bed partners of the rest they ... of the population snores and 20 million people in ... only 10% have been diagnosed and treated; and of ...
(Date:8/30/2014)... The new review published by Daily Gossip reveals ... Brimeyer, who wanted to make her guide accessible to sufferers ... now easy to find in the form of an eBook, ... author of the new method shares all her tips and ... in its review that the leaky gut syndrome can be ...
(Date:8/30/2014)... LiveStreamingFitness.com, a company dedicated to providing live ... resources, is proud to announce it has been recognized as ... fitness solutions by ABC’s Good Morning America. ... Good Morning America, “Live Streaming Fitness is the hottest new ... by streamlining your workout…to boot camp at Life Streaming Fitness ...
Breaking Medicine News(10 mins):Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2
... spent socializing raised peoples, test scores, researchers say , ... gab could boost brainpower, new research suggests. , A ... 10 minutes a day improves memory and test scores. ... as more traditional kinds of mental exercise in boosting ...
... toddler years, study finds , FRIDAY, Nov. 16 (HealthDay News) ... how a child,s nervous system will develop through its toddler ... National Institutes of Health researchers checked fetal heart rate and ... decreases within a specific time period -- six times from ...
... Speaker Nancy Pelosi,will join Congressmen Ciro D. ... to discuss the State Children,s Health,Insurance Program (SCHIP) ... children., WHO: Speaker Nancy Pelosi Congressman ... (TX-20) Congressman Henry Cuellar (TX-28), WHAT: ...
... America,s Seniors, WASHINGTON, Nov. 16 A ... (OIG) finding that in Medicare Part D,generic drugs ... generic,substitutes were available and that 56 percent of ... benefit manager (PBM) tools are,driving down prescription drug ...
... Cancer Early Detection and,Treatment Research Trust Fund, WASHINGTON, ... Susan Fargo, the Senate Chair of the Joint,Committee on ... for lung cancer research., "This is a watershed ... those at risk for the disease in Massachusetts," said ...
... WASHINGTON, Nov. 16 House Republican Whip,Roy Blunt ... alleged "compromise" offer to reduce their spending demands ... Democrats offered to ,compromise, and reduce their demand,for ... billion.,Interestingly, this offer did not include anything about ...
Cached Medicine News:Health News:Talking With Others May Make You Smarter 2Health News:Fetal Heart Rate Points to Later Child Development 2Health News:New OIG Report Confirms Part D Plans Are Driving Generic Utilization 2Health News:Lung Cancer Alliance Hails Massachusetts Senator for Taking Lead on Lung Cancer Legislation 2
This fixed-volume digital micropipet is used to accurately measure and transfer 5 microliters of solution....
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
10L...
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
Medicine Products: